Zaklady Przemyslu Mieszko S.A.- Company Capsule

iCD Research
November 26, 2011
21 Pages - SKU: ICDR6690127
Rec2Rec Agencies (UK) - Industry Report
4/1/2015 | published by: Plimsoll Publishing Ltd.
Plimsoll’s UK Rec2Rec Agencies (UK) analysis is the most definitive and accurate study of the UK Rec2Rec Agencies (UK) sector in 2014. The report is split into two sections and uses both a written and graphical  |  read more...
USD 560
Zoll Medical Corporation - Product Pipeline Analysis, 2015 Update
2/18/2015 | published by: GlobalData
Summary ZOLL Medical Corporation (Zoll) undertakes the designing, manufacturing and marketing of resuscitation devices and systems used for emergency resuscitation of cardiac arrest victims. It develops technologies and software that help clinicians, emergency medical services (EMS)  |  read more...
USD 750
Zeltia Partnering 2009-2014
11/1/2014 | published by: Current Partnering
Zeltia Partnering 2009-2014 The Partnering Agreements with Zeltia 2009-2014 report provides an in-depth insight into the partnering interests and activities of one of the worlds leading biopharma companies. This report provides all the information you require  |  read more...
USD 995
Zimmer Holdings Inc (ZMH: NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
11/6/2014 | published by: Plunkett Research, Ltd.
Zimmer Holdings Inc (ZMH: NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Key Findings: Unique new report provides deep financial benchmarks for (Zimmer Holdings Inc, ZMH: NYS) compared to its  |  read more...
USD 1,795
Dynasil Corporation of America (DYSL) - Product Pipeline Analysis, 2014 Update
10/28/2014 | published by: GlobalData
Summary Dynasil Corporation of America (Dynasil) is a technology service provider. The company develops, manufactures and markets detection, sensing and analysis technology, optical components and precision instruments. It develops funded advanced technology in sensors, materials, and  |  read more...
USD 750
Genera Biosystems Limited (GBI) - Product Pipeline Analysis, 2014 Update
10/28/2014 | published by: GlobalData
Summary Genera Biosystems Limited (GBL) is a diagnostic product company. The company develops and commercializes multiplexed molecular diagnostic testing products. Its products include RTIplex and PapType. GBL’s RTIplex is a multiplexed and automated PCR based test  |  read more...
USD 750
Emulex Corp (ELX: NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
11/13/2014 | published by: Plunkett Research, Ltd.
Emulex Corp (ELX: NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Key Findings: Unique new report provides deep financial benchmarks for (Emulex Corp, ELX: NYS) compared to its top competitors  |  read more...
USD 1,795
Aviat Networks Inc (AVNW: NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
11/13/2014 | published by: Plunkett Research, Ltd.
Aviat Networks Inc (AVNW: NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Key Findings: Unique new report provides deep financial benchmarks for (Aviat Networks Inc, AVNW: NAS) compared to its  |  read more...
USD 1,795
Zambon Company S.p.A. - Product Pipeline Review - 2014
11/14/2014 | published by: Global Markets Direct
Zambon Company S.p.A. - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘Zambon Company S.p.A. - Product Pipeline Review - 2014’, provides an overview of the Zambon Company S.p.A.’s pharmaceutical research and development focus. This report provides  |  read more...
USD 1,500
Zedira GmbH - Product Pipeline Review - 2014
11/14/2014 | published by: Global Markets Direct
Zedira GmbH - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘Zedira GmbH - Product Pipeline Review - 2014’, provides an overview of the Zedira GmbH’s pharmaceutical research and development focus. This report provides comprehensive information on  |  read more...
USD 1,500
 

SELECT A LICENSE

    Online Download  USD 75  
    Global Site License  USD 225  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!